3EO’s proprietary 3TR technology was developed to enable molecular performance at never-before-seen price points across a number of clinical domains to include respiratory and sexually transmitted infections. With a cost per test up to 70% lower than existing technologies, 3EO is seeking to create access to the best technology that is both affordable and easy to use. 3EO Health is currently running programs with key distributor partners for instrument acquisition and on-going utilization that lower costs even further.